{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:51:36Z","timestamp":1792857096502,"version":"4.5.0"},"reference-count":272,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"National Science Center","doi-asserted-by":"publisher","award":["2019\/35\/D\/NZ9\/02989"],"award-info":[{"award-number":["2019\/35\/D\/NZ9\/02989"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Life"],"abstract":"<jats:p>Tissue fibrosis is characterized by excessive deposition of extracellular matrix (ECM) components that result from the disruption of regulatory processes responsible for ECM synthesis, deposition, and remodeling. Fibrosis develops in response to a trigger or injury and can occur in nearly all organs of the body. Thus, fibrosis leads to severe pathological conditions that disrupt organ architecture and cause loss of function. It has been estimated that severe fibrotic disorders are responsible for up to one-third of deaths worldwide. Although intensive research on the development of new strategies for fibrosis treatment has been carried out, therapeutic approaches remain limited. Since stem cells, especially mesenchymal stem cells (MSCs), show remarkable self-renewal, differentiation, and immunomodulatory capacity, they have been intensively tested in preclinical studies and clinical trials as a potential tool to slow down the progression of fibrosis and improve the quality of life of patients with fibrotic disorders. In this review, we summarize in vitro studies, preclinical studies performed on animal models of human fibrotic diseases, and recent clinical trials on the efficacy of allogeneic and autologous stem cell applications in severe types of fibrosis that develop in lungs, liver, heart, kidney, uterus, and skin. Although the results of the studies seem to be encouraging, there are many aspects of cell-based therapy, including the cell source, dose, administration route and frequency, timing of delivery, and long-term safety, that remain open areas for future investigation. We also discuss the contemporary status, challenges, and future perspectives of stem cell transplantation for therapeutic options in fibrotic diseases as well as we present recent patents for stem cell-based therapies in organ fibrosis.<\/jats:p>","DOI":"10.3390\/life11101068","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T09:16:42Z","timestamp":1633943802000},"page":"1068","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Perspective on Stem Cell Therapy in Organ Fibrosis: Animal Models and Human Studies"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5887-450X","authenticated-orcid":false,"given":"Joanna","family":"Wi\u015bniewska","sequence":"first","affiliation":[{"name":"Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, 10-748 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Sadowska","sequence":"additional","affiliation":[{"name":"Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, 10-748 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7978-8117","authenticated-orcid":false,"given":"Anna","family":"W\u00f3jtowicz","sequence":"additional","affiliation":[{"name":"Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, 10-748 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9357-4844","authenticated-orcid":false,"given":"Magda","family":"S\u0142yszewska","sequence":"additional","affiliation":[{"name":"Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, 10-748 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sz\u00f3stek-Mioduchowska","sequence":"additional","affiliation":[{"name":"Institute of Animal Reproduction and Food Research, Polish Academy of Sciences, 10-748 Olsztyn, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1172\/JCI93563","article-title":"Resolution of organ fibrosis","volume":"128","author":"Jun","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"C216","DOI":"10.1152\/ajpcell.00328.2012","article-title":"Cellular mechanisms of tissue fibrosis. 1. Common and organ-specific mechanisms associated with tissue fibrosis","volume":"304","author":"Zeisberg","year":"2013","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4252\/wjsc.v11.i4.212","article-title":"Issues and opportunities of stem cell therapy in autoimmune diseases","volume":"11","author":"Muzes","year":"2019","journal-title":"World J. Stem Cells"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Sivandzade, F., and Cucullo, L. (2021). Regenerative stem cell therapy for neurodegenerative diseases: An overview. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22042153"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/term.2914","article-title":"Mesenchymal stem cells: Cell therapy and regeneration potential","volume":"13","author":"Brown","year":"2019","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Han, Y., Li, X., Zhang, Y., Han, Y., Chang, F., and Ding, J. (2019). Mesenchymal Stem Cells for Regenerative Medicine. Cells, 8.","DOI":"10.3390\/cells8080886"},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Ryu, J.-S., Jeong, E.-J., Kim, J.-Y., Park, S.J., Ju, W.S., Kim, C.-H., Kim, J.-S., and Choo, Y.-K. (2020). Application of Mesenchymal Stem Cells in Inflammatory and Fibrotic Diseases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21218366"},{"key":"ref_9","first-page":"381","article-title":"Osteogenesis in transplants of bone marrow cells","volume":"16","author":"Friedenstein","year":"1966","journal-title":"J. Embryol. Exp. Morphol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1634\/stemcells.21-1-105","article-title":"Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord","volume":"21","author":"Romanov","year":"2003","journal-title":"Stem Cells"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1093\/humrep\/dem265","article-title":"Co-expression of two perivascular cell markers isolates mesenchymal stem-like cells from human endometrium","volume":"22","author":"Schwab","year":"2007","journal-title":"Hum. Reprod."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1089\/107632701300062859","article-title":"Multilineage cells from human adipose tissue: Implications for cell-based therapies","volume":"7","author":"Zuk","year":"2001","journal-title":"Tissue Eng."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3727\/096368910X520065","article-title":"Locally Administered Adipose-Derived Stem Cells Accelerate Wound Healing through Differentiation and Vasculogenesis","volume":"20","author":"Nie","year":"2011","journal-title":"Cell Transplant."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ymthe.2017.09.023","article-title":"Stem Cell Secretome and Its Effect on Cellular Mechanisms Relevant to Wound Healing","volume":"26","author":"Park","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1177\/0963689718766324","article-title":"Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson\u2019s Disease","volume":"27","author":"Kim","year":"2018","journal-title":"Cell Transpl."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1742-2094-10-106","article-title":"Anti-inflammatory and immunomodulatory mechanisms of mesenchymal stem cell transplantation in experimental traumatic brain injury","volume":"10","author":"Zhang","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.stem.2017.07.011","article-title":"BD Humphreys and S Bellusci. Mesenchymal Stem Cells in Fibrotic Disease","volume":"21","author":"Kramann","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","article-title":"Recent Developments in Myofibroblast Biology: Paradigms for Connective Tissue Remodeling","volume":"180","author":"Hinz","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1172\/JCI200320530","article-title":"Epithelial-mesenchymal transition and its implications for fibrosis","volume":"112","author":"Kalluri","year":"2003","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"13180","DOI":"10.1073\/pnas.0605669103","article-title":"Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix","volume":"103","author":"Kim","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1002\/art.38990","article-title":"Myofibroblasts in Murine Cutaneous Fibrosis Originate From Adiponectin-Positive Intradermal Progenitors","volume":"67","author":"Marangoni","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2007.02.003","article-title":"Expression of MMPs and TIMPs in liver fibrosis\u2014A systematic review with special emphasis on anti-fibrotic strategies","volume":"46","author":"Hemmann","year":"2007","journal-title":"J. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1126\/science.1176009","article-title":"The extracellular matrix: Not just pretty fibrils","volume":"326","author":"Hynes","year":"2009","journal-title":"Science"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/gast.1996.v110.pm8608892","article-title":"Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver","volume":"110","author":"Benyon","year":"1996","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0092-8674(00)80064-1","article-title":"MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover","volume":"99","author":"Holmbeck","year":"1999","journal-title":"Cell"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1046\/j.1523-1755.2001.059002543.x","article-title":"A novel model to study renal myofibroblast formation in vitro","volume":"59","author":"Grupp","year":"2001","journal-title":"Kidney Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1242\/jcs.108.3.985","article-title":"Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring","volume":"108","author":"Shah","year":"1995","journal-title":"J. Cell Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/art.22328","article-title":"Postnatal induction of transforming growth factor beta signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma","volume":"56","author":"Sonnylal","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Wojcik-Pszczola, K., Chlon-Rzepa, G., Jankowska, A., Slusarczyk, M., Ferdek, P.E., Kusiak, A.A., Swierczek, A., Pociecha, K., Koczurkiewicz-Adamczyk, P., and Wyska, E. (2020). A Novel, Pan-PDE Inhibitor Exerts Anti-Fibrotic Effects in Human Lung Fibroblasts via Inhibition of TGF-beta Signaling and Activation of cAMP\/PKA Signaling. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21114008"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nature02006","article-title":"Smad-dependent and Smad-independent pathways in TGF-beta family signalling","volume":"425","author":"Derynck","year":"2003","journal-title":"Nature"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","article-title":"Transforming growth factor beta\u2014At the centre of systemic sclerosis","volume":"10","author":"Lafyatis","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/ncomms1734","article-title":"Activation of canonical Wnt signalling is required for TGF-beta-mediated fibrosis","volume":"3","author":"Akhmetshina","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1681\/ASN.2008060566","article-title":"Wnt\/beta-catenin signaling promotes renal interstitial fibrosis","volume":"20","author":"He","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1002\/art.34444","article-title":"Hedgehog signaling controls fibroblast activation and tissue fibrosis in systemic sclerosis","volume":"64","author":"Horn","year":"2012","journal-title":"Arthritis Rheum."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1136\/annrheumdis-2016-210834","article-title":"Elevated serum levels of sonic hedgehog are associated with fibrotic and vascular manifestations in systemic sclerosis","volume":"77","author":"Beyer","year":"2018","journal-title":"Ann. Rheum. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41419-018-1032-9","article-title":"Suppression of SUN2 by DNA methylation is associated with HSCs activation and hepatic fibrosis","volume":"9","author":"Chen","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1053\/jhep.2002.32524","article-title":"Hypoxia-induced VEGF and collagen I expressions are associated with angiogenesis and fibrogenesis in experimental cirrhosis","volume":"35","author":"Corpechot","year":"2002","journal-title":"Hepatology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41581-019-0110-2","article-title":"Macrophages: Versatile players in renal inflammation and fibrosis","volume":"15","author":"Tang","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1126\/science.1242281","article-title":"Plasticity of epithelial stem cells in tissue regeneration","volume":"344","author":"Blanpain","year":"2014","journal-title":"Science"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.arcmed.2020.08.006","article-title":"Mesenchymal Stem Cells Current Clinical Applications: A Systematic Review","volume":"52","author":"Caplan","year":"2021","journal-title":"Arch. Med. Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/6940283","article-title":"Stem Cells Applications in Regenerative Medicine and Disease Therapeutics","volume":"2016","author":"Mahla","year":"2016","journal-title":"Int. J. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1365-2184.2004.00298.x","article-title":"Embryonic stem cells","volume":"37","author":"Rippon","year":"2004","journal-title":"Cell Prolif."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/107632702760240463","article-title":"Derivation of Type II Alveolar Epithelial Cells from Murine Embryonic Stem Cells","volume":"8","author":"Ali","year":"2002","journal-title":"Tissue Eng."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1089\/107632700300003323","article-title":"Differentiation of Osteoblasts andin VitroBone Formation from Murine Embryonic Stem Cells","volume":"7","author":"Buttery","year":"2001","journal-title":"Tissue Eng."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0925-4773(99)00339-1","article-title":"Embryonic stem cell-derived chondrogenic differentiation in vitro: Activation by BMP-2 and BMP-4","volume":"92","author":"Kramer","year":"2000","journal-title":"Mech. Dev."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/bst0310045","article-title":"Neural differentiation of mouse embryonic stem cells","volume":"31","author":"Stavridis","year":"2003","journal-title":"Biochem. Soc. Trans."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1182\/blood-2002-06-1877","article-title":"Effective contribution of transplanted vascular progenitor cells derived from embryonic stem cells to adult neovascularization in proper differentiation stage","volume":"101","author":"Itoh","year":"2003","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-1-61779-201-4_3","article-title":"Embryonic Stem Cell Derivation from Human Embryos","volume":"767","author":"Lerou","year":"2011","journal-title":"Methods Mol. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nrm3448","article-title":"Induced pluripotent stem cells: The new patient?","volume":"13","author":"Bellin","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/CIRCRESAHA.110.240010","article-title":"Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart","volume":"109","author":"Ahmed","year":"2011","journal-title":"Circ. Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"31601","DOI":"10.1074\/jbc.M806597200","article-title":"Generation of Insulin-secreting Islet-like Clusters from Human Skin Fibroblasts","volume":"283","author":"Tateishi","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"5856","DOI":"10.1073\/pnas.0801677105","article-title":"Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson\u2019s disease","volume":"105","author":"Wernig","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.jacc.2016.01.083","article-title":"Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine","volume":"67","author":"Sayed","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_56","first-page":"393","article-title":"The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells","volume":"3","author":"Friedenstein","year":"1970","journal-title":"Cell. Tissue Kinet."},{"key":"ref_57","first-page":"25","article-title":"Regenerative potential of dental pulp mesenchymal stem cells harvested from high caries patient\u2019s teeth","volume":"8","author":"Rajendran","year":"2013","journal-title":"J. Stem. Cells"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s12015-006-0022-y","article-title":"Stem cells in the umbilical cord","volume":"2","author":"Weiss","year":"2006","journal-title":"Stem Cell Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1634\/stemcells.2005-0342","article-title":"Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue","volume":"24","author":"Kern","year":"2006","journal-title":"Stem Cells"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1091\/mbc.e02-02-0105","article-title":"Human adipose tissue is a source of multipotent stem cells","volume":"13","author":"Zuk","year":"2002","journal-title":"Mol. Biol. Cell"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000124281","article-title":"In vitro Differentiation Potential of Mesenchymal Stem Cells","volume":"35","author":"Gimble","year":"2008","journal-title":"Transfus. Med. Hemother."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/01.RES.0000265074.83288.09","article-title":"Adipose-derived stem cells for regenerative medicine","volume":"100","author":"Gimble","year":"2007","journal-title":"Circ Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s12015-013-9456-1","article-title":"In vitro mesenchymal trilineage differentiation and extracellular matrix production by adipose and bone marrow derived adult equine multipotent stromal cells on a collagen scaffold","volume":"9","author":"Xie","year":"2013","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s12015-020-10049-y","article-title":"Adipose-Derived Stromal\/Stem Cells from Large Animal Models: From Basic to Applied Science","volume":"17","author":"Bukowska","year":"2021","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_66","first-page":"483","article-title":"Systemic Infusion of Autologous Adipose Tissue-Derived Mesenchymal Stem Cells in Peritoneal Dialysis Patients: Feasibility and Safety","volume":"20","author":"Alatab","year":"2019","journal-title":"Cell J."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1007\/s11033-020-05505-4","article-title":"Adipose derived mesenchymal stem cell treatment in experimental asherman syndrome induced rats","volume":"47","author":"Cil","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1681\/ASN.2017020151","article-title":"Autologous Mesenchymal Stem Cells Increase Cortical Perfusion in Renovascular Disease","volume":"28","author":"Saad","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3389\/fphar.2017.00633","article-title":"Cell-Based Therapies for Tissue Fibrosis","volume":"8","author":"Lim","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"581828","DOI":"10.3389\/fmolb.2020.581828","article-title":"Long-Term Follow-Up of Patients With Idiopathic Pulmonary Fibrosis Treated With Pirfenidone or Nintedanib: A Real-Life Comparison Study","volume":"7","author":"Cameli","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1800230","DOI":"10.1183\/13993003.00230-2018","article-title":"Safety of nintedanib added to pirfenidone treatment for idiopathic pulmonary fibrosis","volume":"52","author":"Flaherty","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"8407","DOI":"10.1073\/pnas.1432929100","article-title":"Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects","volume":"100","author":"Ortiz","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1165\/rcmb.2004-0330OC","article-title":"Bone marrow-derived mesenchymal stem cells in repair of the injured lung","volume":"33","author":"Rojas","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"14608","DOI":"10.1038\/s41598-017-15022-3","article-title":"Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia","volume":"7","author":"Kotani","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"192","DOI":"10.15283\/ijsc16041","article-title":"Human Adipose-derived Mesenchymal Stem Cells Attenuate Early Stage of Bleomycin Induced Pulmonary Fibrosis: Comparison with Pirfenidone","volume":"9","author":"Reddy","year":"2016","journal-title":"Int. J. Stem. Cells"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.trsl.2015.09.004","article-title":"Therapeutic benefits of young, but not old, adipose-derived mesenchymal stem cells in a chronic mouse model of bleomycin-induced pulmonary fibrosis","volume":"166","author":"Tashiro","year":"2015","journal-title":"Transl. Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3727\/096368909788809857","article-title":"Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis","volume":"18","author":"Cargnoni","year":"2009","journal-title":"Cell Transpl."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2353\/ajpath.2009.080629","article-title":"Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury","volume":"175","author":"Moodley","year":"2009","journal-title":"Am. J. Pathol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"675","DOI":"10.5966\/sctm.2013-0142","article-title":"Differentiation of mouse induced pluripotent stem cells into alveolar epithelial cells in vitro for use in vivo","volume":"3","author":"Zhou","year":"2014","journal-title":"Stem Cells Transl. Med."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fphar.2016.00430","article-title":"Induced Pluripotent Stem Cells Inhibit Bleomycin-Induced Pulmonary Fibrosis in Mice through Suppressing TGF-beta1\/Smad-Mediated Epithelial to Mesenchymal Transition","volume":"7","author":"Zhou","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/scrt513","article-title":"The secretome of induced pluripotent stem cells reduces lung fibrosis in part by hepatocyte growth factor","volume":"5","author":"Gazdhar","year":"2014","journal-title":"Stem Cell Res. Ther."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/sctm.19-0037","article-title":"First-in-human high-cumulative-dose stem cell therapy in idiopathic pulmonary fibrosis with rapid lung function decline","volume":"9","author":"Averyanov","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"ref_83","first-page":"7568","article-title":"Intravenous stem cell dose and changes in quantitative lung fibrosis and DLCO in the AETHER trial: A pilot study","volume":"23","author":"Fishman","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.chest.2016.10.061","article-title":"Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical Trial","volume":"151","author":"Glassberg","year":"2017","journal-title":"Chest"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/1479-5876-11-171","article-title":"A prospective, non-randomized, no placebo-controlled, phase Ib clinical trial to study the safety of the adipose derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis","volume":"11","author":"Tzouvelekis","year":"2013","journal-title":"J. Transl. Med."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2468-1253(16)30081-4","article-title":"Screening for liver fibrosis in the general population: A call for action","volume":"1","author":"Gines","year":"2016","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","article-title":"Mechanisms of hepatic fibrogenesis","volume":"134","author":"Friedman","year":"2008","journal-title":"Gastroenterology"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Patel, V., and Preedy, V. (2017). Biomarkers of Extracellular Matrix Remodeling in Liver Diseases. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications, Springer.","DOI":"10.1007\/978-94-007-7693-7"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0168-8278(99)80327-4","article-title":"Hepatic stellate cells and the regulation of liver inflammation","volume":"31","author":"Marra","year":"1999","journal-title":"J. Hepatol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1042\/CBI20090386","article-title":"Mesenchymal stem cell infusion therapy in a carbon tetrachloride-induced liver fibrosis model affects matrix metalloproteinase expression","volume":"34","author":"Rabani","year":"2010","journal-title":"Cell Biol. Int."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.clinbiochem.2007.04.017","article-title":"Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis","volume":"40","author":"Atta","year":"2007","journal-title":"Clin. Biochem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.3748\/wjg.v11.i22.3431","article-title":"Bone marrow-derived mesenchymal stem cells protect against experimental liver fibrosis in rats","volume":"11","author":"Zhao","year":"2005","journal-title":"World J. Gastroenterol."},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Li, Q., Zhou, X., Shi, Y., Li, J., Zheng, L., Cui, L., Zhang, J., Wang, L., Han, Z., and Han, Y. (2013). In vivo tracking and comparison of the therapeutic effects of MSCs and HSCs for liver injury. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0062363"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.lfs.2009.08.003","article-title":"Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis","volume":"85","author":"Chang","year":"2009","journal-title":"Life Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1007\/s00441-013-1727-2","article-title":"Improvement of liver fibrosis by infusion of cultured cells derived from human bone marrow","volume":"354","author":"Tanimoto","year":"2013","journal-title":"Cell Tissue Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.3727\/096368912X652959","article-title":"Adipose-derived stem cells can abrogate chemical-induced liver fibrosis and facilitate recovery of liver function","volume":"21","author":"Harn","year":"2012","journal-title":"Cell Transplant."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/j.1872-034X.2009.00506.x","article-title":"Therapeutic potential and related signal pathway of adipose-derived stem cell transplantation for rat liver injury","volume":"39","author":"Liang","year":"2009","journal-title":"Hepatol. Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"6317","DOI":"10.1002\/jcp.26439","article-title":"Cell tracking, survival, and differentiation capacity of adipose-derived stem cells after engraftment in rat tissue","volume":"233","author":"Munoz","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1478-3231.2009.02031.x","article-title":"Effect of human umbilical cord blood-derived mesenchymal stem cells in a cirrhotic rat model","volume":"29","author":"Jung","year":"2009","journal-title":"Liver Int."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/lt.21715","article-title":"The therapeutic potential of human umbilical mesenchymal stem cells from Wharton\u2019s jelly in the treatment of rat liver fibrosis","volume":"15","author":"Tsai","year":"2009","journal-title":"Liver Transpl."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/scd.2012.0395","article-title":"Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis","volume":"22","author":"Li","year":"2013","journal-title":"Stem Cells Dev."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1634\/stemcells.2007-0941","article-title":"Bone marrow multipotent mesenchymal stromal cells do not reduce fibrosis or improve function in a rat model of severe chronic liver injury","volume":"26","author":"Carvalho","year":"2008","journal-title":"Stem Cells"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1399-0012.2009.01191.x","article-title":"Bone marrow cells obtained from cirrhotic rats do not improve function or reduce fibrosis in a chronic liver disease model","volume":"25","author":"Mannheimer","year":"2011","journal-title":"Clin. Transpl."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/MEG.0b013e3283488b00","article-title":"Clinical and laboratory evaluation of patients with end-stage liver cell failure injected with bone marrow-derived hepatocyte-like cells","volume":"23","author":"Amer","year":"2011","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/ctr.12179","article-title":"Short-term evaluation of autologous transplantation of bone marrow-derived mesenchymal stem cells in patients with cirrhosis: Egyptian study","volume":"27","author":"Amin","year":"2013","journal-title":"Clin. Transplant."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s12015-011-9322-y","article-title":"Phase II trial: Undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis","volume":"8","author":"Mogawer","year":"2012","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/liv.12218","article-title":"Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: A pilot study","volume":"34","author":"Jang","year":"2014","journal-title":"Liver Int."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","article-title":"Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: A phase I-II clinical trial","volume":"21","author":"Kharaziha","year":"2009","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/liv.12228","article-title":"Randomized placebo-controlled trial of mesenchymal stem cell transplantation in decompensated cirrhosis","volume":"33","author":"Mohamadnejad","year":"2013","journal-title":"Liver Int."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1002\/hep.24434","article-title":"Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes","volume":"54","author":"Peng","year":"2011","journal-title":"Hepatology"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.reth.2016.12.001","article-title":"Phase I clinical study of liver regenerative therapy for cirrhosis by intrahepatic arterial infusion of freshly isolated autologous adipose tissue-derived stromal\/stem (regenerative) cell","volume":"6","author":"Sakai","year":"2017","journal-title":"Regen. Ther."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1440-1746.2011.07024.x","article-title":"Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients","volume":"27","author":"Zhang","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jhep.2009.01.028","article-title":"Homing of bone marrow mesenchymal stem cells mediated by sphingosine 1-phosphate contributes to liver fibrosis","volume":"50","author":"Li","year":"2009","journal-title":"J. Hepatol."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2006.01.036","article-title":"The bone marrow functionally contributes to liver fibrosis","volume":"130","author":"Russo","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s12551-020-00738-w","article-title":"Imaging tools for assessment of myocardial fibrosis in humans: The need for greater detail","volume":"12","author":"Hassan","year":"2020","journal-title":"Biophys. Rev."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","article-title":"Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration","volume":"365","author":"Talman","year":"2016","journal-title":"Cell Tissue Res."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3389\/fphys.2020.00301","article-title":"Leukocyte-Dependent Regulation of Cardiac Fibrosis","volume":"11","author":"Okyere","year":"2020","journal-title":"Front. Physiol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"318","DOI":"10.3389\/fcell.2019.00318","article-title":"Cardiac Fibroblasts and Cardiac Fibrosis: Precise Role of Exosomes","volume":"7","author":"Ranjan","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s40824-016-0060-8","article-title":"Antifibrotic therapies to control cardiac fibrosis","volume":"20","author":"Fan","year":"2016","journal-title":"Biomater. Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"e10865","DOI":"10.15252\/emmm.201910865","article-title":"Targeting cardiac fibrosis in heart failure with preserved ejection fraction: Mirage or miracle?","volume":"12","author":"Sweeney","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"7717","DOI":"10.1111\/jcmm.15479","article-title":"Radiation-induced myocardial fibrosis: Mechanisms underlying its pathogenesis and therapeutic strategies","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s40119-020-00199-y","article-title":"Myocardial Fibrosis in Heart Failure: Anti-Fibrotic Therapies and the Role of Cardiovascular Magnetic Resonance in Drug Trials","volume":"9","author":"Webber","year":"2020","journal-title":"Cardiol. Ther."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1152\/physrev.00019.2015","article-title":"Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue","volume":"96","author":"Golpanian","year":"2016","journal-title":"Physiol. Rev."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1002\/stem.169","article-title":"Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction","volume":"27","author":"Mias","year":"2009","journal-title":"Stem Cells"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"6296","DOI":"10.1038\/s41598-017-06571-8","article-title":"In vivo imaging to monitor differentiation and therapeutic effects of transplanted mesenchymal stem cells in myocardial infarction","volume":"7","author":"Pei","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","article-title":"Randomized Comparison of Allogeneic Versus Autologous Mesenchymal Stem Cells for Nonischemic Dilated Cardiomyopathy: POSEIDON-DCM Trial","volume":"69","author":"Hare","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0022-2828(03)00211-6","article-title":"Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart","volume":"35","author":"Kudo","year":"2003","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1432-2277.2008.00742.x","article-title":"Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure","volume":"21","author":"Li","year":"2008","journal-title":"Transpl. Int."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1161\/CIRCULATIONAHA.104.500447","article-title":"Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy","volume":"112","author":"Nagaya","year":"2005","journal-title":"Circulation"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1161\/CIRCULATIONAHA.109.871905","article-title":"Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction","volume":"121","author":"Tang","year":"2010","journal-title":"Circulation"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1253\/circj.69.1275","article-title":"Selective down-regulation of extracellular matrix gene expression by bone marrow derived stem cell transplantation into infarcted myocardium","volume":"69","author":"Xu","year":"2005","journal-title":"Circ. J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1080\/14653240802129893","article-title":"Immuno-inflammatory regulation effect of mesenchymal stem cell transplantation in a rat model of myocardial infarction","volume":"10","author":"Du","year":"2008","journal-title":"Cytotherapy"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.yjmcc.2006.10.003","article-title":"Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis","volume":"42","author":"Ohnishi","year":"2007","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Feng, Y., Huang, W., Wani, M., Yu, X., and Ashraf, M. (2014). Ischemic preconditioning potentiates the protective effect of stem cells through secretion of exosomes by targeting Mecp2 via miR-22. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0088685"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1007\/s12265-018-9822-0","article-title":"Transplantation of Cardiac Mesenchymal Stem Cell-Derived Exosomes Promotes Repair in Ischemic Myocardium","volume":"11","author":"Ju","year":"2018","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Kishore, R., Verma, S.K., Mackie, A.R., Vaughan, E.E., Abramova, T.V., Aiko, I., and Krishnamurthy, P. (2013). Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0060161"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1016\/j.febslet.2007.07.028","article-title":"Mesenchymal stem cells attenuate cardiac fibroblast proliferation and collagen synthesis through paracrine actions","volume":"581","author":"Ohnishi","year":"2007","journal-title":"FEBS Lett."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ijcard.2014.12.043","article-title":"Exosomes secreted from GATA-4 overexpressing mesenchymal stem cells serve as a reservoir of anti-apoptotic microRNAs for cardioprotection","volume":"182","author":"Yu","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1161\/CIRCRESAHA.116.304360","article-title":"Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology","volume":"116","author":"Gray","year":"2015","journal-title":"Circ. Res."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"33700","DOI":"10.1038\/srep33700","article-title":"Mesenchymal Stem Cells Combined with Hepatocyte Growth Factor Therapy for Attenuating Ischaemic Myocardial Fibrosis: Assessment using Multimodal Molecular Imaging","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/s13287-017-0722-z","article-title":"MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction","volume":"8","author":"Chen","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/nm912","article-title":"Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts","volume":"9","author":"Mangi","year":"2003","journal-title":"Nat. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"9108681","DOI":"10.1155\/2018\/9108681","article-title":"IGF-1-Overexpressing Mesenchymal Stem\/Stromal Cells Promote Immunomodulatory and Proregenerative Effects in Chronic Experimental Chagas Disease","volume":"2018","author":"Silva","year":"2018","journal-title":"Stem Cells Int."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/stem.789","article-title":"Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice","volume":"30","author":"Hoke","year":"2012","journal-title":"Stem Cells"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.yjmcc.2009.04.005","article-title":"Hyperbaric oxygenation enhances transplanted cell graft and functional recovery in the infarct heart","volume":"47","author":"Khan","year":"2009","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1161\/01.RES.0000225952.61196.39","article-title":"Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling","volume":"98","author":"Uemura","year":"2006","journal-title":"Circ. Res."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/jpet.109.150839","article-title":"Pharmacological preconditioning of mesenchymal stem cells with trimetazidine (1-[2,3,4-trimethoxybenzyl]piperazine) protects hypoxic cells against oxidative stress and enhances recovery of myocardial function in infarcted heart through Bcl-2 expression","volume":"329","author":"Wisel","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.actbio.2013.10.027","article-title":"Evaluation of polyelectrolyte complex-based scaffolds for mesenchymal stem cell therapy in cardiac ischemia treatment","volume":"10","author":"Ceccaldi","year":"2014","journal-title":"Acta Biomater."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/j.jss.2012.01.028","article-title":"Localization of mesenchymal stem cells grafted with a hyaluronan-based scaffold in the infarcted heart","volume":"179","author":"Fiumana","year":"2013","journal-title":"J. Surg. Res."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ijcard.2014.03.015","article-title":"Direct implantation versus platelet-rich fibrin-embedded adipose-derived mesenchymal stem cells in treating rat acute myocardial infarction","volume":"173","author":"Sun","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/1535370214560957","article-title":"Enhanced infarct myocardium repair mediated by thermosensiive copolymer hydrogel-based stem cell transplantation","volume":"240","author":"Xia","year":"2015","journal-title":"Exp. Biol. Med."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/01.RES.0000027865.61704.32","article-title":"Differentiation of pluripotent embryonic stem cells into cardiomyocytes","volume":"91","author":"Boheler","year":"2002","journal-title":"Circ. Res."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3727\/096368914X679200","article-title":"Akt-mTOR Pathway Inhibits Apoptosis and Fibrosis in Doxorubicin-Induced Cardiotoxicity Following Embryonic Stem Cell Transplantation","volume":"24","author":"Singla","year":"2015","journal-title":"Cell Transpl."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3727\/096368911X627552","article-title":"Embryonic stem cells improve cardiac function in Doxorubicin-induced cardiomyopathy mediated through multiple mechanisms","volume":"21","author":"Singla","year":"2012","journal-title":"Cell Transpl."},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"H1308","DOI":"10.1152\/ajpheart.01277.2006","article-title":"Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling","volume":"293","author":"Singla","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.3727\/096368911X627561","article-title":"Overexpression of TIMP-1 in embryonic stem cells attenuates adverse cardiac remodeling following myocardial infarction","volume":"21","author":"Glass","year":"2012","journal-title":"Cell Transpl."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1161\/CIRCRESAHA.111.262584","article-title":"Mitotically inactivated embryonic stem cells can be used as an in vivo feeder layer to nurse damaged myocardium after acute myocardial infarction: A preclinical study","volume":"111","author":"Burt","year":"2012","journal-title":"Circ. Res."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCRESAHA.117.305990","article-title":"Embryonic stem cell-derived exosomes promote endogenous repair mechanisms and enhance cardiac function following myocardial infarction","volume":"117","author":"Khan","year":"2015","journal-title":"Circ. Res."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.ymthe.2018.05.009","article-title":"Mesenchymal Stem Cell-Based Therapy for Cardiovascular Disease: Progress and Challenges","volume":"26","author":"Bagno","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1242\/dmm.000240","article-title":"Cardiac repair and regeneration: The Rubik\u2019s cube of cell therapy for heart disease","volume":"2","author":"Boudoulas","year":"2009","journal-title":"Dis. Model. Mech."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1161\/CIRCRESAHA.117.311827","article-title":"Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients with Ischemic Cardiomyopathy (The TRIDENT Study)","volume":"121","author":"Florea","year":"2017","journal-title":"Circ. Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41419-020-2542-9","article-title":"The therapeutic potential of mesenchymal stem cells for cardiovascular diseases","volume":"11","author":"Guo","year":"2020","journal-title":"Cell Death Dis."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/jocs.13789","article-title":"The current status of stem cell therapy in ischemic heart disease","volume":"33","author":"Michler","year":"2018","journal-title":"J. Card. Surg."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1161\/CIRCRESAHA.117.310712","article-title":"Safety and Efficacy of the Intravenous Infusion of Umbilical Cord Mesenchymal Stem Cells in Patients With Heart Failure: A Phase 1\/2 Randomized Controlled Trial (RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy])","volume":"121","author":"Bartolucci","year":"2017","journal-title":"Circ. Res."},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Gao, L.R., Chen, Y., Zhang, N.K., Yang, X.L., Liu, H.L., Wang, Z.G., Yan, X.Y., Wang, Y., Zhu, Z.M., and Li, T.C. (2015). Intracoronary infusion of Wharton\u2019s jelly-derived mesenchymal stem cells in acute myocardial infarction: Double-blind, randomized controlled trial. BMC Med., 13.","DOI":"10.1186\/s12916-015-0399-z"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1002\/sctm.17-0040","article-title":"Cryopreserved Off-the-Shelf Allogeneic Adipose-Derived Stromal Cells for Therapy in Patients with Ischemic Heart Disease and Heart Failure-A Safety Study","volume":"6","author":"Kastrup","year":"2017","journal-title":"Stem Cells Transl. Med."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.jacc.2007.07.054","article-title":"Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts","volume":"50","author":"Caspi","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.semnephrol.2010.03.004","article-title":"Macrophages and renal fibrosis","volume":"30","author":"Vernon","year":"2010","journal-title":"Semin. Nephrol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1369\/0022155419849388","article-title":"Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold","volume":"67","author":"Bulow","year":"2019","journal-title":"J. Histochem. Cytochem."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mam.2018.06.002","article-title":"Cellular and molecular mechanisms of kidney fibrosis","volume":"65","author":"Djudjaj","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mam.2017.05.001","article-title":"Specialized pro-resolving mediators in renal fibrosis","volume":"58","author":"Brennan","year":"2017","journal-title":"Mol. Asp. Med."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.matbio.2017.12.013","article-title":"Renal fibrosis: Recent translational aspects","volume":"68\u201369","author":"Francois","year":"2018","journal-title":"Matrix Biol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/j.ackd.2016.11.002","article-title":"Treatment of Renal Fibrosis-Turning Challenges into Opportunities","volume":"24","author":"Klinkhammer","year":"2017","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.4110\/in.2019.19.e36","article-title":"Mesenchymal Stem Cells Ameliorate Renal Inflammation in Adriamycin-induced Nephropathy","volume":"19","author":"Kim","year":"2019","journal-title":"Immune Netw."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00441-017-2602-3","article-title":"Transplantation of bone marrow-derived MSCs improves renal function and Na(+)+K(+)-ATPase activity in rats with renovascular hypertension","volume":"369","author":"Lira","year":"2017","journal-title":"Cell Tissue Res."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1002\/stem.214","article-title":"Mesenchymal stem cells attenuate renal fibrosis through immune modulation and remodeling properties in a rat remnant kidney model","volume":"27","author":"Semedo","year":"2009","journal-title":"Stem Cells"},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Wu, H.J., Yiu, W.H., Li, R.X., Wong, D.W., Leung, J.C., Chan, L.Y., Zhang, Y., Lian, Q., Lin, M., and Tse, H.F. (2014). Mesenchymal stem cells modulate albumin-induced renal tubular inflammation and fibrosis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090883"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.3727\/096368912X640448","article-title":"Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats","volume":"21","author":"Alfarano","year":"2012","journal-title":"Cell Transpl."},{"key":"ref_180","first-page":"109","article-title":"Functional, histological and biochemical consequences of renal lymph disorder in mononephrectomized rats","volume":"22","author":"Zhang","year":"2009","journal-title":"J. Nephrol."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/ajt.13180","article-title":"Renal allograft fibrosis: Biology and therapeutic targets","volume":"15","author":"Boor","year":"2015","journal-title":"Am. J. Transpl."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/ndt\/gfu230","article-title":"Cell cycle arrest and the evolution of chronic kidney disease from acute kidney injury","volume":"30","author":"Canaud","year":"2015","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"70707","DOI":"10.18632\/oncotarget.19979","article-title":"Adipose-derived mesenchymal stem cells employed exosomes to attenuate AKI-CKD transition through tubular epithelial cell dependent Sox9 activation","volume":"8","author":"Zhu","year":"2017","journal-title":"Oncotarget"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/ndt\/gfr015","article-title":"Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury","volume":"26","author":"Gatti","year":"2011","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fcell.2020.00188","article-title":"Mesenchymal Stem Cell Derived Extracellular Vesicles Ameliorate Kidney Injury in Aristolochic Acid Nephropathy","volume":"8","author":"Kholia","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"4468","DOI":"10.1038\/s41598-019-41100-9","article-title":"Stem cell-derived extracellular vesicles inhibit and revert fibrosis progression in a mouse model of diabetic nephropathy","volume":"9","author":"Grange","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13287-020-01792-7","article-title":"Protective effect of miRNA-containing extracellular vesicles derived from mesenchymal stromal cells of old rats on renal function in chronic kidney disease","volume":"11","author":"Wang","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"9806","DOI":"10.1002\/jcp.29794","article-title":"Adjunctive mesenchymal stem\/stromal cells augment microvascular function in poststenotic kidneys treated with low-energy shockwave therapy","volume":"235","author":"Chen","year":"2020","journal-title":"J. Cell Physiol."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/ndt\/gft305","article-title":"Renal vein cytokine release as an index of renal parenchymal inflammation in chronic experimental renal artery stenosis","volume":"29","author":"Eirin","year":"2014","journal-title":"Nephrol. Dial. Transpl."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1089\/scd.2020.0030","article-title":"Mesenchymal Stem\/Stromal Cells and their Extracellular Vesicle Progeny Decrease Injury in Poststenotic Swine Kidney Through Different Mechanisms","volume":"29","author":"Zhao","year":"2020","journal-title":"Stem Cells Dev."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13287-015-0012-6","article-title":"Mesenchymal stem cell-derived microparticles ameliorate peritubular capillary rarefaction via inhibition of endothelial-mesenchymal transition and decrease tubulointerstitial fibrosis in unilateral ureteral obstruction","volume":"6","author":"Choi","year":"2015","journal-title":"Stem Cell Res. Ther."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"9425","DOI":"10.7150\/thno.43315","article-title":"Exosomes derived from GDNF-modified human adipose mesenchymal stem cells ameliorate peritubular capillary loss in tubulointerstitial fibrosis by activating the SIRT1\/eNOS signaling pathway","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"ref_193","first-page":"262","article-title":"Role of Mesenchymal Stem Cells Transfected With Vascular Endothelial Growth Factor in Maintaining Renal Structure and Function in Rats with Unilateral Ureteral Obstruction","volume":"13","author":"Ozbek","year":"2015","journal-title":"Exp. Clin. Transpl."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/mt.2016.90","article-title":"Mesenchymal Stem Cells Deliver Exogenous MicroRNA-let7c via Exosomes to Attenuate Renal Fibrosis","volume":"24","author":"Wang","year":"2016","journal-title":"Mol. Ther."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"508","DOI":"10.4103\/ijmr.IJMR_1527_16","article-title":"Influence of hepatocyte growth factor-transfected bone marrow-derived mesenchymal stem cells towards renal fibrosis in rats","volume":"149","author":"Xie","year":"2019","journal-title":"Indian J. Med. Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1096\/fj.14-254789","article-title":"Combination therapy of mesenchymal stem cells and serelaxin effectively attenuates renal fibrosis in obstructive nephropathy","volume":"29","author":"Huuskes","year":"2015","journal-title":"FASEB J."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"108093","DOI":"10.1016\/j.diabres.2020.108093","article-title":"Mesenchymal stem cells modified with angiotensin-converting enzyme 2 are superior for amelioration of glomerular fibrosis in diabetic nephropathy","volume":"162","author":"Liu","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41598-020-79664-6","article-title":"Interferon-gamma enhances the therapeutic effect of mesenchymal stem cells on experimental renal fibrosis","volume":"11","author":"Kanai","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10735-019-09812-4","article-title":"Melatonin preconditioning of bone marrow-derived mesenchymal stem cells promotes their engraftment and improves renal regeneration in a rat model of chronic kidney disease","volume":"50","author":"Saberi","year":"2019","journal-title":"J. Mol. Histol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/0963689718815850","article-title":"Transplantation of Amniotic Fluid-Derived Stem Cells Preconditioned with Glial Cell Line-Derived Neurotrophic Factor Gene Alleviates Renal Fibrosis","volume":"28","author":"Li","year":"2019","journal-title":"Cell Transpl."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"3847171","DOI":"10.1155\/2020\/3847171","article-title":"Mouse Umbilical Cord Mesenchymal Stem Cell Paracrine Alleviates Renal Fibrosis in Diabetic Nephropathy by Reducing Myofibroblast Transdifferentiation and Cell Proliferation and Upregulating MMPs in Mesangial Cells","volume":"2020","author":"Li","year":"2020","journal-title":"J. Diabetes Res."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13287-017-0760-6","article-title":"Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4\/NF-kappaB signaling pathway in vivo and in vitro","volume":"9","author":"Liu","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/MAJ.0b013e3182831777","article-title":"Human umbilical mesenchymal stem cells attenuate the progression of focal segmental glomerulosclerosis","volume":"346","author":"Ma","year":"2013","journal-title":"Am. J. Med. Sci."},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.transproceed.2012.03.044","article-title":"Delayed treatment with human umbilical cord blood-derived stem cells attenuates diabetic renal injury","volume":"44","author":"Park","year":"2012","journal-title":"Transplant. Proc."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s13287-020-01852-y","article-title":"Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis","volume":"11","author":"Xiang","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"173343","DOI":"10.1016\/j.ejphar.2020.173343","article-title":"Human umbilical cord mesenchymal stem cell attenuates renal fibrosis via TGF-beta\/Smad signaling pathways in vivo and in vitro","volume":"883","author":"Yu","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbrc.2005.08.136","article-title":"Wnt4-transformed mouse embryonic stem cells differentiate into renal tubular cells","volume":"336","author":"Kobayashi","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ki.2012.442","article-title":"Human embryonic stem cells differentiate into functional renal proximal tubular-like cells","volume":"83","author":"Narayanan","year":"2013","journal-title":"Kidney Int."},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"392","DOI":"10.4103\/0366-6999.176088","article-title":"Embryonic Stem Cells-loaded Gelatin Microcryogels Slow Progression of Chronic Kidney Disease","volume":"129","author":"Geng","year":"2016","journal-title":"Chin. Med. J."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1681\/ASN.2013040367","article-title":"Renal cells from spermatogonial germline stem cells protect against kidney injury","volume":"25","author":"Fagoonee","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.scr.2016.06.001","article-title":"Generation of functional podocytes from human induced pluripotent stem cells","volume":"17","author":"Ciampi","year":"2016","journal-title":"Stem Cell Res."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1038\/s41598-019-39504-8","article-title":"Directed Differentiation of Human Pluripotent Stem Cells to Podocytes under Defined Conditions","volume":"9","author":"Qian","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s13287-020-02060-4","article-title":"Therapeutic potential of human induced pluripotent stem cells and renal progenitor cells in experimental chronic kidney disease","volume":"11","author":"Ribeiro","year":"2020","journal-title":"Stem Cell Res. Ther."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"7428316","DOI":"10.1155\/2017\/7428316","article-title":"Induced Pluripotent Stem Cells Reduce Progression of Experimental Chronic Kidney Disease but Develop Wilms\u2019 Tumors","volume":"2017","author":"Caldas","year":"2017","journal-title":"Stem Cells Int."},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.2016101150","article-title":"Allogeneic Mesenchymal Stem Cells for Treatment of AKI after Cardiac Surgery","volume":"29","author":"Swaminathan","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13287-017-0557-7","article-title":"Safety and tolerability of autologous bone marrow mesenchymal stromal cells in ADPKD patients","volume":"8","author":"Makhlough","year":"2017","journal-title":"Stem Cell Res. Ther."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1055\/s-0034-1376358","article-title":"Endometrial receptivity and intrauterine adhesive disease","volume":"32","author":"Young","year":"2014","journal-title":"Semin. Reprod. Med."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.fertnstert.2008.02.096","article-title":"Asherman syndrome\u2014One century later","volume":"89","author":"Yu","year":"2008","journal-title":"Fertil. Steril."},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0031-1272470","article-title":"Asherman\u2019s syndrome","volume":"29","author":"March","year":"2011","journal-title":"Semin. Reprod. Med."},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/humrep\/12.5.943","article-title":"Successful treatment of severe uterine synechiae with transcervical resectoscopy combined with laminaria tent","volume":"12","author":"Chen","year":"1997","journal-title":"Hum. Reprod."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"1223.e3","DOI":"10.1016\/j.fertnstert.2017.02.113","article-title":"Prevalence of intrauterine adhesions after the application of hyaluronic acid gel after dilatation and curettage in women with at least one previous curettage: Short-term outcomes of a multicenter, prospective randomized controlled trial","volume":"107","author":"Hooker","year":"2017","journal-title":"Fertil. Steril."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.fertnstert.2015.04.008","article-title":"Randomized, controlled trial comparing the efficacy of intrauterine balloon and intrauterine contraceptive device in the prevention of adhesion reformation after hysteroscopic adhesiolysis","volume":"104","author":"Lin","year":"2015","journal-title":"Fertil. Steril."},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0028-2243(95)02315-J","article-title":"Etiology of and therapeutic approach to synechia uteri","volume":"65","author":"Schenker","year":"1996","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Alawadhi, F., Du, H., Cakmak, H., and Taylor, H.S. (2014). Bone Marrow-Derived Stem Cell (BMDSC) transplantation improves fertility in a murine model of Asherman\u2019s syndrome. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0096662"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/jhrs.JHRS_64_19","article-title":"Autologous Bone Marrow-Derived Stem Cell Therapy for Asherman\u2019s Syndrome and Endometrial Atrophy: A 5-Year Follow-up Study","volume":"13","author":"Singh","year":"2020","journal-title":"J. Hum. Reprod. Sci."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"1552.e1-3","DOI":"10.1016\/j.fertnstert.2015.08.032","article-title":"Human CD133(+) bone marrow-derived stem cells promote endometrial proliferation in a murine model of Asherman syndrome","volume":"104","author":"Cervello","year":"2015","journal-title":"Fertil. Steril."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13287-018-0801-9","article-title":"Human mesenchymal stem cells in spheroids improve fertility in model animals with damaged endometrium","volume":"9","author":"Domnina","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s13287-019-1368-9","article-title":"Human amniotic epithelial cells improve fertility in an intrauterine adhesion mouse model","volume":"10","author":"Li","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1093\/humrep\/dew042","article-title":"Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman\u2019s syndrome and endometrial atrophy: A pilot cohort study","volume":"31","author":"Santamaria","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s43032-019-00055-y","article-title":"Effect of Autologous Adipose-Derived Stromal Vascular Fraction Transplantation on Endometrial Regeneration in Patients of Asherman\u2019s Syndrome: A Pilot Study","volume":"27","author":"Lee","year":"2020","journal-title":"Reprod. Sci."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s13287-018-0904-3","article-title":"Allogeneic cell therapy using umbilical cord MSCs on collagen scaffolds for patients with recurrent uterine adhesion: A phase I clinical trial","volume":"9","author":"Cao","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1093\/humrep\/dew235","article-title":"Autologous menstrual blood-derived stromal cells transplantation for severe Asherman\u2019s syndrome","volume":"31","author":"Tan","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jdermsci.2013.03.005","article-title":"Fibrosing connective tissue disorders of the skin: Molecular similarities and distinctions","volume":"70","author":"Canady","year":"2013","journal-title":"J. Dermatol. Sci."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/1529-0131(200011)43:11<2598::AID-ANR30>3.0.CO;2-8","article-title":"Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride","volume":"43","author":"Christner","year":"2000","journal-title":"Arthritis Rheum."},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.4049\/jimmunol.0803705","article-title":"Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse","volume":"182","author":"Servettaz","year":"2009","journal-title":"J. Immunol."},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1346-8138.2009.00764.x","article-title":"Animal model of systemic sclerosis","volume":"37","author":"Yamamoto","year":"2010","journal-title":"J. Dermatol."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/art.30312","article-title":"Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: A novel mouse model for scleroderma?","volume":"63","author":"Wei","year":"2011","journal-title":"Arthritis. Rheum."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0738-081X(94)90323-9","article-title":"Epidemiology of systemic sclerosis","volume":"12","author":"Medsger","year":"1994","journal-title":"Clin. Dermatol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1159\/000131502","article-title":"Scleroderma","volume":"10","author":"Gilliam","year":"2008","journal-title":"Curr. Dir. Autoimmun."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/nature07039","article-title":"Wound repair and regeneration","volume":"453","author":"Gurtner","year":"2008","journal-title":"Nature"},{"key":"ref_241","first-page":"350","article-title":"Scarless Skin Wound Repair in the Fetus","volume":"159","author":"Lorenz","year":"1993","journal-title":"West. J. Med."},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3181\/00379727-187-42694","article-title":"Type I and type III collagen content of healing wounds in fetal and adult rats","volume":"187","author":"Merkel","year":"1988","journal-title":"Proc. Soc. Exp. Biol Med."},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/exd.14121","article-title":"Hypertrophic scars and keloids: Overview of the evidence and practical guide for differentiating between these abnormal scars","volume":"30","author":"Limandjaja","year":"2021","journal-title":"Exp. Dermatol."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.stem.2012.03.007","article-title":"Mesenchymal-stem-cell-induced immunoregulation involves FAS-ligand-\/FAS-mediated T cell apoptosis","volume":"10","author":"Akiyama","year":"2012","journal-title":"Cell Stem Cell"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/cr.2017.11","article-title":"Mesenchymal stem cell transplantation in tight-skin mice identifies miR-151-5p as a therapeutic target for systemic sclerosis","volume":"27","author":"Chen","year":"2017","journal-title":"Cell Res."},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/art.39477","article-title":"Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis","volume":"68","author":"Maria","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1756-185X.13764","article-title":"Adipose-derived stromal\/stem cells successfully attenuate the fibrosis of scleroderma mouse models","volume":"23","author":"Okamura","year":"2020","journal-title":"Int. J. Rheum. Dis."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1002\/jcp.26418","article-title":"Mesenchymal stromal cells prevent bleomycin-induced lung and skin fibrosis in aged mice and restore wound healing","volume":"233","author":"Rubio","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_249","doi-asserted-by":"crossref","unstructured":"Domergue, S., Bony, C., Maumus, M., Toupet, K., Frouin, E., Rigau, V., Vozenin, M.C., Magalon, G., Jorgensen, C., and Noel, D. (2016). Comparison between Stromal Vascular Fraction and Adipose Mesenchymal Stem Cells in Remodeling Hypertrophic Scars. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0156161"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.burns.2017.08.017","article-title":"Human adipose tissue-derived stem cells inhibit the activity of keloid fibroblasts and fibrosis in a keloid model by paracrine signaling","volume":"44","author":"Liu","year":"2018","journal-title":"Burns"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s42358-021-00166-8","article-title":"Hematopoietic stem cell transplantation for systemic sclerosis: Brazilian experience","volume":"61","author":"Vasconcelos","year":"2021","journal-title":"Adv. Rheumatol."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/S0140-6736(11)60982-3","article-title":"Autologous non-myeloablative haemopoietic stem-cell transplantation compared with pulse cyclophosphamide once per month for systemic sclerosis (ASSIST): An open-label, randomised phase 2 trial","volume":"378","author":"Burt","year":"2011","journal-title":"Lancet"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1001\/jama.2014.6368","article-title":"Autologous hematopoietic stem cell transplantation vs intravenous pulse cyclophosphamide in diffuse cutaneous systemic sclerosis: A randomized clinical trial","volume":"311","author":"Farge","year":"2014","journal-title":"JAMA"},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa1703327","article-title":"Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma","volume":"378","author":"Sullivan","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3727\/096368912X639017","article-title":"Human adipose-derived stromal cells for cell-based therapies in the treatment of systemic sclerosis","volume":"22","author":"Scuderi","year":"2013","journal-title":"Cell Transpl."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1136\/annrheumdis-2014-205681","article-title":"Safety, tolerability and potential efficacy of injection of autologous adipose-derived stromal vascular fraction in the fingers of patients with systemic sclerosis: An open-label phase I trial","volume":"74","author":"Granel","year":"2015","journal-title":"Ann. Rheum Dis."},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Almadori, A., Griffin, M., Ryan, C.M., Hunt, D.F., Hansen, E., Kumar, R., Abraham, D.J., Denton, C.P., and Butler, P.E.M. (2019). Stem cell enriched lipotransfer reverses the effects of fibrosis in systemic sclerosis. PLoS ONE, 14.","DOI":"10.1371\/journal.pone.0218068"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3727\/096368914X674062","article-title":"Autologous fat grafting in the treatment of fibrotic perioral changes in patients with systemic sclerosis","volume":"24","author":"Caviggioli","year":"2015","journal-title":"Cell Transpl."},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1096\/fj.06-6769com","article-title":"Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response","volume":"21","author":"Nussbaum","year":"2007","journal-title":"FASEB J."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cell.2008.02.008","article-title":"Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development","volume":"132","author":"Murry","year":"2008","journal-title":"Cell"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nbt1393","article-title":"Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo","volume":"26","author":"Kroon","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/scd.2007.0266","article-title":"Teratoma formation by human embryonic stem cells is site dependent and enhanced by the presence of Matrigel","volume":"18","author":"Prokhorova","year":"2009","journal-title":"Stem Cells Dev."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0002-9440(10)62041-X","article-title":"Formation of human myocardium in the rat heart from human embryonic stem cells","volume":"167","author":"Laflamme","year":"2005","journal-title":"Am. J. Pathol."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1136\/jme.2008.024786","article-title":"The significance of induced pluripotent stem cells for basic research and clinical therapy","volume":"34","author":"Meyer","year":"2008","journal-title":"J. Med. Ethics"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1172\/JCI40553","article-title":"Progress toward the clinical application of patient-specific pluripotent stem cells","volume":"120","author":"Kiskinis","year":"2010","journal-title":"J. Clin. Investig."},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2006-12-063412","article-title":"Potential risks of bone marrow cell transplantation into infarcted hearts","volume":"110","author":"Breitbach","year":"2007","journal-title":"Blood"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1161\/01.CIR.0000134696.08436.65","article-title":"Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction","volume":"109","author":"Yoon","year":"2004","journal-title":"Circulation"},{"key":"ref_268","doi-asserted-by":"crossref","unstructured":"Portalska, K.J., Leferink, A., Groen, N., Fernandes, H., Moroni, L., van Blitterswijk, C., and de Boer, J. (2012). Endothelial differentiation of mesenchymal stromal cells. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046842"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1634\/stemcells.22-3-377","article-title":"Mesenchymal stem cells can be differentiated into endothelial cells in vitro","volume":"22","author":"Oswald","year":"2004","journal-title":"Stem Cells"},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"C684","DOI":"10.1152\/ajpcell.00114.2014","article-title":"ABCG2pos lung mesenchymal stem cells are a novel pericyte subpopulation that contributes to fibrotic remodeling","volume":"307","author":"Marriott","year":"2014","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.stem.2017.03.008","article-title":"Gli1(+) Mesenchymal Stromal Cells Are a Key Driver of Bone Marrow Fibrosis and an Important Cellular Therapeutic Target","volume":"20","author":"Schneider","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1161\/CIRCRESAHA.110.239848","article-title":"Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy","volume":"108","author":"Jeong","year":"2011","journal-title":"Circ. Res."}],"container-title":["Life"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-1729\/11\/10\/1068\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:11:28Z","timestamp":1760166688000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-1729\/11\/10\/1068"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":272,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["life11101068"],"URL":"https:\/\/doi.org\/10.3390\/life11101068","relation":{},"ISSN":["2075-1729"],"issn-type":[{"value":"2075-1729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]}}}